• 1
    United Network for Organ Sharing, Richmond VA. 2002.
  • 2
    United States Scientific Renal Transplant Registry (SRTR). Annual Report. 2001.
  • 3
    Xue JL, Ma JZ, Louis TA et al. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001; 12: 27532758.
  • 4
    Danovitch GM, Hariharan S, Pirsch JD et al. Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Soc Nephrol 2002; 13: 528536.
  • 5
    Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 17251730.
  • 6
    Meier-Kriesche HU, Port FK, Ojo AO et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58: 13111317.
  • 7
    National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (Suppl. 1): S1S266.
  • 8
    Qualheim RE, Rostand SG, Kirk KA, Rutsky EA, Luke RG. Changing patterns of end stage renal disease due to hypertension. Am J Kidney Dis 1991; 18: 336343.
  • 9
    United States Renal Data System (USRDS). Annual Data Report. Minneapolis, MN; 2001.
  • 10
    Wolfe RA, Ashby VB, Milford EL et al. Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis 2000; 36: 10251033.
  • 11
    Ayanian JZ, Cleary PD, Weissman JS, Epstein AM. The effect of patient's preferences on racial differences in access to renal transplantation. N Engl J Med 1999; 341: 16611669.
  • 12
    Ashby VB, Leichtman AB, Wolfe RA et al. Racial differences, by state, in access to wait listing and renal transplantation in the United States (Abstract). Am J Transplant 2001; 1 (Suppl. 1): 357.
  • 13
    Garg PP, Frick KD, Diener-West M, Powe NR. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation. N Engl J Med 1999; 341: 16531660.
  • 14
    Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA 1998; 280: 11481154.
  • 15
    Kasiske BL, London W, Ellison M. Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J Am Soc Nephrol 1998; 9: 21422147.
  • 16
    Thamer M, Henderson SC, Ray NF, Rinehart CS, Greer JW, Danovitch GM. Unequal access to cadaveric kidney transplantation in California based on insurance status. Health Services Res 1999; 34: 879900.
  • 17
    Young CJ, Gaston RS. Renal transplantation in black Americans. N Engl J Med 2000; 343: 15451552.
  • 18
    Noonan SJ, Armistead N, Cleary PD et al. Racial disparities in access to renal transplantation: clinically appropriate or due to underuse or overuse? N Engl J Med 2000; 343: 15371544.
  • 19
    Alexander GC, Sehgal AR. Why hemodialysis patients fail to complete the transplantation process. Am J Kidney Dis 2001; 37: 321328.
  • 20
    Gaston RS. Evolution of Medicare policy involving transplantation and immunosuppressive medications: past developments and future directions. In: FieldMJ, LawrenceRL, ZwanzigerL, eds. Extending Medicare Coverage for Preventive and Other Services. Washington, DC: National Academy Press; 2000. pp D23D38.
  • 21
    Matas AJ, Garvey CA, Jacobs CL, Kahn JP. Nondirected donation of kidneys from living donors. N Engl J Med 2000; 343: 433436.
  • 22
    Ojo AO, Hanson JA, Meier-Kriesche HU et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12: 589597.
  • 23
    Office of Inspector General of the Department of Health and Human Services. Clinical Performance Measures for Dialysis Facilities: Building on the Experiences of the Dialysis corporations. Washington, DC: 2002 January.
  • 24
    Zavala EY, Rogers JC, First MR, Woodle ES. Potential negative impact on academic kidney transplant programs by the Balanced Budget Act of 1997 that extends ESRD coordination of benefits to 30 months (Abstract). Am J Transplant 2002; 2 (Suppl. 3): 262.
  • 25
    Gornick ME, Eggers PW, Reilly TW et al. Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med 1996; 335: 791799.
  • 26
    Tankersley MR, Gaxton RS, Curtis JJ et al. The living donor process in kidney transplantation: influence of race and comorbidity. Transplant Proc 1997; 29: 37223723.
  • 27
    National Institute of Diabetes, Digestive, Kidney Diseases (NIDDK). National Kidney Disease Education Program http://www.nkdep.nih.gov2001.
  • 28
    Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000; 343: 10781084.
  • 29
    Wynn JJ, Port FK, Wolfe RA et al. The effect of HLA B and DR points on access to kidney transplantation and graft failure by race and ethnicity in the US (Abstract). Am J Transplant 2002; 2 (Suppl. 3): 146.
  • 30
    Ellison MD, McBride M, Taranto S, Delmonico FL, Kauffman M. Living kidney donors in need of kidney transplants: a report from the OPTN. Transplantation 2002; 74: 13491351.
  • 31
    Danovitch GM, Cohen B, Smits J. Waiting time or wasted time. The case for using time on dialysis to determine waiting time in the allocation of cadaveric kidneys. Am J Transplant 2002; 3: 891893.
  • 32
    Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplant candidates: clinical practice guidelines. J Am Transplant 2001; 2 (Suppl. 1): 595.
  • 33
    Meier-Kriesche H, Port FK, Ojo AO et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58: 13111317.
  • 34
    Delmonico FL, Wynn J. Managing the enlarging wait list. Am J Transplant 2002; 2: 889890.
  • 35
    Steiberg EP, Eknoyan G, Levin NW et al. Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: description, findings, and implications. Am J Kidney Dis 2000; 36: 112.
  • 36
    Matas AJ, Kasiske B, Miller L. Proposed guidelines for re-evaluation of patients on the waiting list for renal cadaver transplantation. Transplantation 2002; 73: 811831.
  • 37
    Danovitch GM. The epidemic of cardiovascular disease in chronic renal failure: a challenge to transplant physicians. Graft 1999; 2: 51085112.
  • 38
    CDC. Recommendations for preventing transmission of infections among chronic hemodialysis patients. Morb Mortal Wkly Rep 2001; 50: 141.
  • 39
    Schaffner A. Pretransplant evaluation for infections in donors and recipients of solid organs. Clin Infect Dis 2001; 33 (Suppl. 1): S9S14.
  • 40
    CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. Morb Mortal Wkly Rep 2000; 49: 151.
  • 41
    Mahanty H, Lou C, Chang J, Roberts J, Baxter-Lowe LA. What are your chances of getting a zero mismatched kidney? (Abstract 138 presented at the American Transplant Congress, Chicago, May 2001). Am J Transplant 2001; 1 (Suppl. 1): 170.
  • 42
    Alfrey EJ, Lu AD, Carter JT, Dafoe DC. Matching does not improve outcome from aged marginal kidney donors. Transplant Proc 2001; 33: 11621163.
  • 43
    Port FK, Bragg-Gresham JL, Metzger RA et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002; 74: 12811286.
  • 44
    Rosengard BR, Feng S, Alfrey E et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002; 2: 701711.
  • 45
    Merion RM, Ashby VB, Wolfe RA et al. Mortality risk for expanded donor kidney recipients compared with waitlisted dialysis patients. Am Soc Nephrol 2002: 13: Abstract #SU-FC231.